Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications cost effectiveness oral contraceptives compared ‘no hormonal treatment‘ endometriosis
Webinar: The End of Significance Testing Share on: Thursday, March 28, 2019, 10 - 11am Watch the recording The use of statistical significance testing in epidemiological research Null hypothesis significance testing is not dead, but in this webinar, Ken …
… the formation of newly regenerated tissue following treatment. Prior to this, Dr. Campbell completed an … benefit of a novel co-implantation cell therapy for the treatment of cartilage-bone defects, and the effects …
Lynda Doward Patient-Centered Outcomes Assessment Oncology Medical Technologies Infectious Disease Hematology Diabetes & Endocrine Disorders CNS/Neurology Cardiovascular Autoimmune Diseases Rheumatology Respiratory Psychiatry Manchester, United Kingdom …
… reviews, health technology assessment submissions, cost-effectiveness and budget-impact analyses, model adaptations, … handling materials, key opinion leader interviews, and publications. Dr. Pearson’s therapy area experience includes …
… analyses, health economics and outcomes research, cost-effectiveness analysis, and decision modeling. Dr. Karanth …
… Obstructive Pulmonary Disease, Journal of Comparative Effectiveness Research, and the Journal of Managed Care & …
Incorporating Real-World Evidence Into Your Product Development Transcript: It's critical to understand how to incorporate real-world evidence at every stage of your drug or device development journey. You need to understand where your product fits in the …
… Patients' willingness to accept adverse event and cost trade-offs for reduced risk of non-melanoma skin …
… are among the most prescribed drugs in Europe. However, no studies have described their use and the characteristics … Citalopram and mirtazapine were used as first-line treatment, and agomelatine and duloxetine were used as second-line treatment. Based on the results of the study, we concluded …
Nuria Saigi-Morgui Pharmacoepidemiology and Risk Management Barcelona, Spain PhD, Pharmacogenetics University of Lausanne, Lausanne, Switzerland MPH, School of Life Sciences Pompeu Fabra University, Barcelona, Spain PharmMSc, School of Pharmacy University …